ProfileGDS4132 / 201756_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 83% 79% 86% 84% 81% 83% 84% 86% 81% 80% 85% 84% 87% 86% 84% 85% 86% 86% 86% 80% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101297.02883
GSM201543Muscle PCOS pioglitazone 121249.3279
GSM201544Muscle PCOS pioglitazone 161368.9986
GSM201545Muscle PCOS pioglitazone 201342.69684
GSM201829Muscle PCOS pioglitazone 231295.6581
GSM201830Muscle PCOS pioglitazon 251301.21483
GSM201831Muscle PCOS pioglitazone 271322.62784
GSM201832Muscle PCOS pioglitazone 31331.48386
GSM201833Muscle PCOS pioglitazone 41283.10881
GSM201834Muscle PCOS pioglitazone 81281.67680
GSM201835Muscle PCOS after pioglitazone 102344.37285
GSM201836Muscle PCOS after pioglitazone 122327.68184
GSM201837Muscle PCOS after pioglitazone 162352.45987
GSM201838Muscle PCOS after pioglitazone 202382.24186
GSM201839Muscle PCOS after pioglitazone 232336.67384
GSM201840Muscle PCOS after pioglitazone 252367.86385
GSM201841Muscle PCOS after pioglitazone 272343.55386
GSM201842Muscle PCOS after pioglitazone 32330.06986
GSM201843Muscle PCOS after pioglitazone 42363.79186
GSM201844Muscle PCOS after pioglitazone 82290.3680